By Michael O'Reilly at Stockchase Premium
Member since: Jul '20 · 3338 Opinions
Curated by Michael O'Reilly since 2020
1550+ opinions with
4.81 rating (one of the best performing expert)
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
The diversified holder of financial equity assets uses leverage to further enhance market returns of its portfolio. Currently the company holds about 12% debt, which is trending lower. Its yield is backed by a payout ratio under 15% of cash flow. It presently trades at 5x earnings, under book value and supports a 13% ROE. We recommend trailing up the stop (from $35.50) to $40.50, looking to achieve $58.00 -- upside potential of 28%. Yield 2.3%
(Analysts’ price target is $169.00)Stock price when the opinion was issued
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
RPRX is the largest buyer of biopharma royalties in the world. They draw their value from providing innovative financing to pharma partners, while sharing in the top line revenue of the new products developed. Deloitte just released a study highlighting the importance of royalties in new pharma development -- and RPRX leads the way. It trades at 8x earnings, 2.2x book and supports a 25% ROE. Quarterly cashflow is cautiously being used to aggressively buy back shares. We recommend maintaining a stop at $34.50, looking to achieve $45 -- upside potential of 25%. Yield 2.4%
(Analysts’ price target is $44.67)Stock price when the opinion was issued
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Our PAST TOP PICK with HUT is progressing well. To remain disciplined, we recommend trailing up the stop (from $28.50) to $33.00 at this time.
Stock price when the opinion was issued
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Curated by Michael O'Reilly since 2020.
1550+ opinions with
4.81 rating (one of the best performing expert).
Build your watch list
Sign in to track investments
you care about
The salon operator of the SuperCuts brand recently reported an operating income increase of 15% along with a 22% growth in revenues. Cash reserves are growing, albeit along with rising debt. It trades at 11x earnings and trades under book value. We recommend maintaining a stop at $19, looking to achieve $36 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $40.00)